The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

BACKGROUND: Breast cancer (BC) is a heterogeneous disease characterised by variant biology and patient outcome. The amino acid transporter, SLC7A5, plays a role in BC although its impact on patient outcome in different BC subtypes remains to be validated. This study aimed to determine whether the cl...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Cancer Res
Главные авторы: El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863851/
https://ncbi.nlm.nih.gov/pubmed/29566741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-0946-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы